zdask
Home
/
Health
/
Providers Combat Vaccine Hesitancy After Johnson & Johnson Vaccine Pause
Providers Combat Vaccine Hesitancy After Johnson & Johnson Vaccine Pause-April 2024
Apr 2, 2026 11:22 PM

Health officials recommended a pause on the Johnson & Johnson COVID-19 vaccine on Tuesday after six people experienced rare but severe blood clots.

The six adverse reactions to the vaccine were experienced by women aged 18 to 48 and resulted in one death. In ajoint statement issued Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said the “these adverse events appear to be extremely rare.”

As of Tuesday, more than 6.8 million doses of the Johnson & Johnson vaccine had been administered.

Health care providers are urging the public to get the currently approved and authorized Pfizer or Moderna vaccines instead.

Dr. Juanita Mora, an allergist and immunologist at the Chicago Allergy Center, said she’s observed vaccine hesitancy in the Latino community and said only about 11% of Illinois’ Latino community has received the COVID-19 vaccine.

“We have a lot of work to do but vaccine hesitancy is going to increase even more,” Mora.

You can read more about the Johnson & Johnson vaccine pause recommendation onthe CDC’s website

Comments
Welcome to zdask comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Health
Copyright 2023-2026 - www.zdask.com All Rights Reserved